<DOC>
	<DOCNO>NCT03092180</DOCNO>
	<brief_summary>As T2T , patient idiopathic inflammatory myopathy receive pulse therapy methyprednisolone and/or human intravenous immunoglobulin , methyprednisolone disease onset . This scheme internal routine protocol Service .</brief_summary>
	<brief_title>Optimizing Treatment Idiopathic Inflammatory Myopathies</brief_title>
	<detailed_description>To compare two group patient describe Brief Summary .</detailed_description>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Myositis</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<criteria>Idiopathic inflammatory myopathy Inclusion body myositis , muscular dystrophy , neoplasiaassociated myopathy , overlap myopathy , others myopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Dermatomyositis</keyword>
	<keyword>Immunomodulation</keyword>
	<keyword>Immunosuppressive agent</keyword>
	<keyword>Myositis</keyword>
	<keyword>Polymyositis</keyword>
	<keyword>Necrotizing myopathy</keyword>
	<keyword>Antisynthetase syndrome</keyword>
</DOC>